![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis... Read Gene therapy offers protection from terrorist attack A gene therapy has shown it could protect vital organs from the damaging effects of ionising radiation during a terrorist attack... Read Sulphur analysis speeds up protein quantification Chinese researchers have developed a way to quickly quantify protein abundance using a mass spectrometry technique (MS) commonly used for elemental analysis... Read 'Legendary' DNA Nobel Prize winner dies Dr Arthur Kornberg, winner of the 1959 Nobel Prize for his work on how DNA is built, has died from respiratory failure at the age of 89... Read The most pioneering drugs at cancer showcase As the AACR-NCI-EORTC cancer conference comes to an end today in San Francisco, DrugResearcher.com takes a look at some of the most innovative drugs on show... Read |
|||||||||||||||||
All News Headlines for: October | September | August |
|||||||||||||||||
![]() Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more... Click Here | |||||||||||||||||
|
Related Industry News Europe's latest drug recommendations Europe's Committee for Medicinal Products for Human Use (CHMP) today released the report from its October meeting, with highlights including GlaxoSmithKline's Avandia (rosiglitazone), Atripla (efavirenz, emtricitabine,... Read Pfizer to cut another 200 jobs Pfizer is already cutting jobs in relation to its failed Exubera with the announcement that some 200 jobs are to go at the drug giant's Portage and Kalamazoo sites, according to local media reports... Read Major Singapore investment for Novartis Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low... Read Ranbaxy's statin a drag on PPD's bottom line PPD's decision to in-license an investigational compound is proving to be a drag on its bottom line as the firm continues to seek a development partner for the drug... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||